About GF FUND MANAGEMENT CO LTD CSI HONG KONG BRAND NAME DRUG INDEX ETF
Expense ratio
0.60%
Home page
Inception date
Jul 1, 2022
ISIN
CNE100005BG9
Tightly track the target index, pursue the minimization of tracking deviation and tracking err. The fund strives to control the absolute value of the daily average tracking deviation between the net value growth rate of the investment portfolio & the performance benchmark is less than 0.2%, & the annualized tracking deviation is less than 0.2%.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks95.81%
Health Technology93.61%
Commercial Services2.05%
Distribution Services0.15%
Bonds, Cash & Other4.19%
Cash3.40%
Miscellaneous0.80%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history